Safety and Efficacy of Twice-Daily Pilocarpine HCl in Presbyopia: The Virgo Phase 3, Randomized, Double-Masked, Controlled Study

To evaluate the safety, efficacy, and pharmacokinetics of pilocarpine hydrochloride 1.25% (Pilo hereafter) compared with vehicle when administered bilaterally, twice daily (6 hours apart) for 14 days in participants with presbyopia. Phase 3, randomized (1:1), controlled, double-masked, multicenter s...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of ophthalmology 2023-09, Vol.253, p.189-200
Hauptverfasser:	Kannarr, Shane, El-Harazi, Sherif M., Moshirfar, Majid, Lievens, Christopher, Kim, Jennifer Lee, Peace, James H., Safyan, Eleonora, Liu, Haixia, Zheng, Suzanne, Robinson, Michael R.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!